Moreover, blocking C1q, C3, or the microglial complement receptor CR3 lowers the quantity of phagocytic microglia and mitigates early synapse loss in mouse models of early Alzheimer’s disease [77]. The gene discussed is CRIPTO3; the disease is Alzheimer disease.